Ajanta Pharma Approves ₹315 Crore Share Buyback At ₹1,425 Apiece Via Tender Offer | Midcap Radar

Ajanta Pharma Ltd. approved its third share buyback in as many years at its board meeting on Friday. The board has approved to buyback 22.1 lakh equity shares of face value of Rs 2 each through the tender offer route. The number of shares to be bought back represent 2.59 percent of the total number of equity shares of the company. #ajantapharma #ajantapharmastocks #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here. You can also connect with CNBC-TV18 News Online Catch the latest news: https://bit.ly/2YbpXBM Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/ Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/ You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/ n18oc_business